Literature DB >> 12738632

Relationship between plasma Interleukin-12 (IL-12) and IL-18 levels and severe malarial anemia in an area of holoendemicity in western Kenya.

Sujittra Chaisavaneeyakorn1, Caroline Othoro, Ya Ping Shi, Juliana Otieno, Sansanee C Chaiyaroj, Altaf A Lal, Venkatachalam Udhayakumar.   

Abstract

In this study, we investigated whether levels of interleukin-12 (IL-12) and IL-18 in plasma are associated with severe malarial anemia outcomes in an area of holoendemicity in western Kenya. We compared plasma IL-12 and IL-18 levels in six groups of children grouped into the categories aparasitemic, asymptomatic, mild malaria, high-density uncomplicated malaria (UC), moderate malarial anemia (MMA), or severe malarial anemia (SMA). IL-12 levels were significantly reduced in children with SMA (P < 0.05) but not in other groups compared to children in the aparasitemic control group. IL-18, a cytokine known to be critical for the induction of gamma interferon along with IL-12, was produced more frequently (70%) in children with UC (P = 0.06) than in children in the aparasitemic control group (32%). However, in the SMA group the IL-18 response rate declined to 30%, which was similar to that in the aparasitemic control group, which showed a 32% response rate. This finding suggests that the IL-18 response may be impaired in children with SMA. In summary, the results from this study support the hypothesis that impairment of IL-12 and/or IL-18 response may contribute to the development of severe malarial anemia in areas of holoendemicity for malaria.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12738632      PMCID: PMC154962          DOI: 10.1128/cdli.10.3.362-366.2003

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  25 in total

1.  Low interleukin-12 activity in severe Plasmodium falciparum malaria.

Authors:  A J Luty; D J Perkins; B Lell; R Schmidt-Ott; L G Lehman; D Luckner; B Greve; P Matousek; K Herbich; D Schmid; J B Weinberg; P G Kremsner
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

2.  Down-regulation of IL-12 p40 gene in Plasmodium berghei-infected mice.

Authors:  X Xu; K Sumita; C Feng; X Xiong; H Shen; S Maruyama; M Kanoh; Y Asano
Journal:  J Immunol       Date:  2001-07-01       Impact factor: 5.422

3.  Changes in cytokine production associated with acquired immunity to Plasmodium falciparum malaria.

Authors:  M S Rhee; B D Akanmori; M Waterfall; E M Riley
Journal:  Clin Exp Immunol       Date:  2001-12       Impact factor: 4.330

4.  Serum levels of interleukin-18 in patients with uncomplicated Plasmodium falciparum malaria.

Authors:  D Torre; M Giola; F Speranza; A Matteelli; C Basilico; G Biondi
Journal:  Eur Cytokine Netw       Date:  2001 Apr-Jun       Impact factor: 2.737

5.  Longitudinal cohort study of the epidemiology of malaria infections in an area of intense malaria transmission II. Descriptive epidemiology of malaria infection and disease among children.

Authors:  P B Bloland; D A Boriga; T K Ruebush; J B McCormick; J M Roberts; A J Oloo; W Hawley; A Lal; B Nahlen; C C Campbell
Journal:  Am J Trop Med Hyg       Date:  1999-04       Impact factor: 2.345

Review 6.  Malaria-related anaemia.

Authors:  C Menendez; A F Fleming; P L Alonso
Journal:  Parasitol Today       Date:  2000-11

7.  The role of IL-18 in blood-stage immunity against murine malaria Plasmodium yoelii 265 and Plasmodium berghei ANKA.

Authors:  Ram Pyare Singh; Shin-ichiro Kashiwamura; Prakash Rao; Haruki Okamura; Askok Mukherjee; Virander Singh Chauhan
Journal:  J Immunol       Date:  2002-05-01       Impact factor: 5.422

8.  Increased levels of interleukin-12 in Plasmodium falciparum malaria: correlation with the severity of disease.

Authors:  Lucia Malaguarnera; Rosa Maria Imbesi; Salvatore Pignatelli; Jacques Simporè; Mariano Malaguarnera; Salvatore Musumeci
Journal:  Parasite Immunol       Date:  2002-07       Impact factor: 2.280

9.  Tumor necrosis factor and severe malaria.

Authors:  N Shaffer; G E Grau; K Hedberg; F Davachi; B Lyamba; A W Hightower; J G Breman; N D Phuc
Journal:  J Infect Dis       Date:  1991-01       Impact factor: 5.226

10.  IL-12-induced protection against blood-stage Plasmodium chabaudi AS requires IFN-gamma and TNF-alpha and occurs via a nitric oxide-dependent mechanism.

Authors:  M M Stevenson; M F Tam; S F Wolf; A Sher
Journal:  J Immunol       Date:  1995-09-01       Impact factor: 5.422

View more
  12 in total

1.  Distinct clinical and immunologic profiles in severe malarial anemia and cerebral malaria in Zambia.

Authors:  Philip E Thuma; Janneke van Dijk; Rick Bucala; Zufan Debebe; Sergei Nekhai; Thea Kuddo; Mehdi Nouraie; Günter Weiss; Victor R Gordeuk
Journal:  J Infect Dis       Date:  2011-01-15       Impact factor: 5.226

2.  Functional promoter haplotypes of interleukin-18 condition susceptibility to severe malarial anemia and childhood mortality.

Authors:  Samuel B Anyona; Prakasha Kempaiah; Evans Raballah; Collins Ouma; Tom Were; Gregory C Davenport; Stephen N Konah; John M Vulule; James B Hittner; Charity W Gichuki; John M Ong'echa; Douglas J Perkins
Journal:  Infect Immun       Date:  2011-10-03       Impact factor: 3.441

3.  TLR9 and MyD88 are crucial for the development of protective immunity to malaria.

Authors:  Nagaraj M Gowda; Xianzhu Wu; D Channe Gowda
Journal:  J Immunol       Date:  2012-04-18       Impact factor: 5.422

4.  Polymorphisms in genes of interleukin 12 and its receptors and their association with protection against severe malarial anaemia in children in western Kenya.

Authors:  Lyna Zhang; Donald Prather; Jodi Vanden Eng; Sara Crawford; Simon Kariuki; Feiko ter Kuile; Dianne Terlouw; Bernard Nahlen; Altaf A Lal; Laurence Slutsker; Venkatachalam Udhayakumar; Ya Ping Shi
Journal:  Malar J       Date:  2010-03-29       Impact factor: 2.979

5.  Plasma interleukin-12 in malaria-tolerant papua new guineans: inverse correlation with Plasmodium falciparum parasitemia and peripheral blood mononuclear cell nitric oxide synthase activity.

Authors:  Craig S Boutlis; Moses Lagog; Sujittra Chaisavaneeyakorn; Mary A Misukonis; Moses J Bockarie; Charles S Mgone; Zhiqiang Wang; Grant Morahan; J Brice Weinberg; Venkatachalam Udhayakumar; Nicholas M Anstey
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

6.  Increased circulating interleukin (IL)-23 in children with malarial anemia: in vivo and in vitro relationship with co-regulatory cytokines IL-12 and IL-10.

Authors:  John M Ong'echa; Allison M Remo; Jan Kristoff; James B Hittner; Tom Were; Collins Ouma; Richard O Otieno; John M Vulule; Christopher C Keller; Gordon A Awandare; Douglas J Perkins
Journal:  Clin Immunol       Date:  2007-10-22       Impact factor: 3.969

7.  Cytokine Profiles in Malawian Children Presenting with Uncomplicated Malaria, Severe Malarial Anemia, and Cerebral Malaria.

Authors:  Wilson L Mandala; Chisomo L Msefula; Esther N Gondwe; Mark T Drayson; Malcolm E Molyneux; Calman A MacLennan
Journal:  Clin Vaccine Immunol       Date:  2017-04-05

8.  Cord Blood IL-12 Confers Protection to Clinical Malaria in Early Childhood Life.

Authors:  Yong Song; Ruth Aguilar; Jing Guo; Maria Nelia Manaca; Augusto Nhabomba; Tamara Katherine Berthoud; Siew-Kim Khoo; Selma Wiertsema; Arnoldo Barbosa; Llorenç Quintó; Ingrid A Laing; Alfredo Mayor; Caterina Guinovart; Pedro L Alonso; Peter N LeSouëf; Carlota Dobaño; Guicheng Brad Zhang
Journal:  Sci Rep       Date:  2018-07-18       Impact factor: 4.379

9.  Preconditioning with hemin decreases Plasmodium chabaudi adami parasitemia and inhibits erythropoiesis in BALB/c mice.

Authors:  Esther Dalko; Véronique Gaudreault; Jaime Sanchez Dardon; Robert Moreau; Tatiana Scorza
Journal:  PLoS One       Date:  2013-01-24       Impact factor: 3.240

10.  The genetic risk of acute seizures in African children with falciparum malaria.

Authors:  Symon M Kariuki; Kirk Rockett; Taane G Clark; Hugh Reyburn; Tsiri Agbenyega; Terrie E Taylor; Gretchen L Birbeck; Thomas N Williams; Charles R J C Newton
Journal:  Epilepsia       Date:  2013-04-24       Impact factor: 5.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.